Background: Development of liver cancer involves alterations of multiple pathways of gene expression. Results: Translational activation of C/EBP-HDAC1 complexes represses p53, SIRT1, and PGC1␣, leading to liver cancer. Conclusion: Modulation of levels of C/EBP-HDAC1 complexes at different stages of cancer is involved in liver cancer. Significance: Understanding the mechanisms of liver cancer is a critical step for the development of therapeutic approaches for cancer.